-
Company Insights
Innovation and Patenting activity of ARC Resources Ltd Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of ARC Resources Ltd Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
Innovation and Patenting activity of Arcs Co Ltd Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Arcs Co Ltd Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-172154 in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-172154 in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-172154 in Epithelial Ovarian Cancer Drug Details: SL-172154 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-172154 in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-172154 in Refractory Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-172154 in Refractory Acute Myeloid Leukemia Drug Details: SL-172154 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-172154 in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-172154 in Metastatic Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-172154 in Metastatic Ovarian Cancer Drug Details: SL-172154 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-172154 in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-172154 in Myelodysplastic Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-172154 in Myelodysplastic Syndrome Drug Details: SL-172154 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-172154 in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-172154 in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-172154 in Relapsed Acute Myeloid Leukemia Drug Details: SL-172154 is...
-
Product Insights
External Remote Patient Monitoring Devices Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies
External Remote Patient Monitoring Devices Pipeline Market Report Overview An External Remote Patient Monitoring Device retrieves the data from the external measurement device such as glucose meters. The device then transmits the data through a wireless system to a monitoring station or a physician’s office for further analysis and interpretation. The External Remote Patient Monitoring Devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report...
-
Product Insights
Vallee de l’Arce
Vallee de l~Arce is an Onshore Wind project located in Grand Est, France. The project is owned by Boralex Inc and was developed by Enel SpA. The project came online in 2009. Empower your strategies with our Vallee de l~Arce report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...